Read + Share
Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, et al. Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of
HER2-Overexpressing Metastatic Breast Cancer. J Clin Oncol 2023;41:1638-1645.
PMID: 36921335
|
 |
|
Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, et al. Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of
HER2-Overexpressing Metastatic Breast Cancer. J Clin Oncol 2023;41:1638-1645.
PMID: 36921335
|
|
|
|